Israeli hospital studies effects of CBD on COVID-19 patients

The study is looking at whether or not cannabidiol can slow down inflammation in severe cases of coronavirus infection

Tinnakorn Jorruang / Getty Images Plus

0

A new study at Ichilov Hospital in Tel Aviv, Israel, will examine the effects of cannabis on patients with COVID-19.

Specifically, the study is looking at whether or not the extract cannabidiol (or CBD) can slow down inflammation in severe cases of coronavirus infection and alleviate symptoms of the illness.

The Jewish Press reports that the study is being conducted “in collaboration with a number of the wards in the hospital and is expected to involve dozens of moderately ill patients.”

CBD has been the subject of clinical research into its effects on anxiety, cognition, movement disorders, and pain, but to date there is insufficient evidence that it is effective for these conditions.

In 2018, however, the U.S. Food and Drug Administration approved the use of the CBD Epidiolex for the treatment of two forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome in children with refractory epilepsy.

Leave your opinion for the editor...We read everything!

Your email address will not be published. Required fields are marked *